Stephen Taub Premium Glenview Gets Off to a Strong Start Larry Robbins’ healthcare-heavy funds delivered gains in February, outperforming the broader market. Stephen Taub March 2, 2022 Larry Robbins (Alex Flynn/Bloomberg)